Ledger.Open graph →
SEC Form D · filed February 17, 2021

Sarkana Pharma, Inc

Offering
—
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Mark Cipriano · Wilmington, DEExecCaroline Fortier · Wilmington, DEExecLuc Marengere · Westmount, Quebec, CanadaDirectorGrant D. King · Perth, WA, Channel IslandsExecPhilip Hulse · Clayton, MOExecPieter Van Staden · Winter Park, FLExecParin Shah · New York, NYExecLuc Marengere · Westmount, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗